Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Boxer Capital
AddedFeb 13, 2024
UpdatedJul 11, 2026
Boxer Capital

Boxer Capital

Operating

Boxer Capital, LLC: A private fund investing and innovating in diverse biotechnology sectors.

Location
San Diego, CA, US
Founded
2005
Firm
Compare
Portfolio
Employees
Website

Boxer Capital, LLC is a private biotechnology investment fund based in San Diego, California. The firm focuses on investing in and innovating within the biotechnology sector, particularly in new therapeutics across multiple indications. Boxer Capital typically participates in Series A, B, and C funding rounds, with a notable presence in post-IPO equity investments as well.

The firm's portfolio includes prominent companies such as Arvinas, SpringWorks Therapeutics, and 2seventy bio. Boxer Capital is known for maintaining a concentrated portfolio of both public and private companies. Their investment philosophy emphasizes integrity and accountability, aiming to support companies that significantly improve medical outcomes. The firm offers unique value-add services to its portfolio companies, leveraging its deep industry expertise and network to drive growth and innovation.

Boxer Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments50
Current Portfolio Count34
Total Portfolio Exits2

Top Investment Stages

Series B17 (36.2%)
Series A11 (23.4%)
Series C9 (19.1%)
Post Ipo Equity7 (14.9%)
Series Unknown3 (6.4%)

Stage Mix

Series B 36%Series A 23%Series C 19%Post Ipo Equity 15%Series Unknown 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Flare Therapeutics logo

Flare Therapeutics

Seismic Therapeutic logo

Seismic Therapeutic

Arvinas logo

Arvinas

Lusaris Therapeutics logo

Lusaris Therapeutics

Alterome Therapeutics logo

Alterome Therapeutics

SpringWorks Therapeutics logo

SpringWorks Therapeutics

Incyclix Bio logo

Incyclix Bio

2seventy bio logo

2seventy bio

Ceptur Therapeutics logo

Ceptur Therapeutics

Shoreline Biosciences logo

Shoreline Biosciences

Asher Bio logo

Asher Bio

Tango Therapeutics logo

Tango Therapeutics

Ajax Therapeutics logo

Ajax Therapeutics

Boundless Bio logo

Boundless Bio

Vividion Therapeutics logo

Vividion Therapeutics

Scorpion Therapeutics logo

Scorpion Therapeutics

Cullinan Oncology logo

Cullinan Oncology

Vivace Therapeutics logo

Vivace Therapeutics

Solid Biosciences logo

Solid Biosciences

Cedilla Therapeutics logo

Cedilla Therapeutics

Encoded Therapeutics logo

Encoded Therapeutics

Fulcrum Therapeutics logo

Fulcrum Therapeutics

iTeos Therapeutics logo

iTeos Therapeutics

Nurix logo

Nurix

Syndax Pharmaceuticals logo

Syndax Pharmaceuticals

Boxer Capital - Classification

Also Known As
  • Boxer Capital ApS
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end